Information:
Error:
Keywords
Alzheimer Disease
×
- Clinical Trial (123)
- Eligibility Determination (73)
- Neurology (26)
- Clinical Trial, Phase II (17)
- Psychiatry (16)
- Drug trial (16)
- Physical Examination (15)
- Adverse event (15)
- Schizophrenia (14)
- Memory Disorders (14)
- Concomitant Medication (9)
- Medical History Taking (9)
- Vital Signs (8)
- End of Study (8)
- Electrocardiogram (ECG) (8)
- Follow-Up Studies (8)
- Trial screening (4)
- Psychomotor Agitation (3)
- Drugs, Investigational (3)
- Clinical Chemistry Tests (3)
- Pharmacogenetics (2)
- Registries (2)
- Urinalysis (2)
- Mild Cognitive Impairment (2)
- Hematology (2)
- Apolipoproteins E (1)
- Pharmacokinetics (1)
- Pregnancy (1)
- Pregnancy Tests (1)
- Respiratory Function Tests (1)
- Medical Laboratory Science (1)
- Therapeutics (1)
- Cognitive Therapy (1)
- Amyloid beta-Peptides (1)
- Comment (1)
- Randomized Controlled Trial (1)
- Caregivers (1)
- Clinical Trial, Phase III (1)
- Event-Related Potentials, P300 (1)
- Positron-Emission Tomography (1)
- Transcriptome (1)
- Pragmatic Clinical Trial (1)
- Demography (1)
- Down Syndrome (1)
- Informed Consent (1)
- Liver (1)
- Patient Dropouts (1)
Table of contents
Selected data models
You must log in to select data models for download or further analysis.
202 Search results.
Itemgroups:
Inclusion Criteria, Exclusion Criteria
Itemgroups:
Administrative documentation, Allen test, Vital signs, Pulmonary function tests, 12 lead ECG, Holter Electrocardiography, Positron-Emission Tomography, Pre-dose, Pharmacokinetic aspects - Blood, Randomization, Numbers, Therapeutic procedure, Confirmation, Experimental drug, Positron-Emission Tomography, Post-dose, Physical Examination, Post-dose, Vital signs, Post-dose, Laboratory Procedures, Post-dose, Hematology finding, Laboratory Procedures, Post-dose, Chemistry, Clinical, Urinalysis, Post-dose, Laboratory Procedures, Post-dose, Renal function
Itemgroups:
Administrative documentation, Investigator Signature
Itemgroups:
Administrative documentation, Clinical Investigators, Comment
Itemgroups:
Administrative documentation, Clinical Trials, Conclusion
Itemgroups:
Administrative documentation, Pregnancy, Information
Itemgroups:
Administrative documentation, Serious Adverse Event, Serious Adverse Event, Seriousness of Adverse Event, Serious Adverse Event, Demography, Serious Adverse Event, Relationships, Experimental drug, Serious Adverse Event, Etiology aspects, Serious Adverse Event, Disease, Serious Adverse Event, Risk factors, Serious Adverse Event, Concomitant Agent, Serious Adverse Event, Experimental drug, Details, Serious Adverse Event, Diagnostic Procedure, Serious Adverse Event, Comment, Serious Adverse Event, Investigator Signature
Itemgroups:
Administrative documentation, Non-serious Adverse Event
Itemgroups:
Administrative documentation, Concomitant Agent
Itemgroups:
Administrative documentation, Pharmacogenetic Test, Informed Consent, Pharmacogenetic Test, Collection of blood specimen for laboratory procedure, Pharmacogenetic Test, Informed Consent, Withdraw, Pharmacogenetic Test, Blood specimen, Destruction
Itemgroups:
Administrative documentation, Liver, Adverse event, Evaluation
Itemgroups:
Administrative documentation, Vital signs, Pulmonary function tests, 12 lead ECG, Physical Examination, Vital signs, Laboratory Procedures, Hematology finding, Laboratory Procedures, Chemistry, Clinical, Urinalysis, Laboratory Procedures, Renal function, Blood, Laboratory Procedures, Renal function, Urine